Forte Capital LLC Gilead Sciences, Inc. Transaction History

Forte Capital LLC

$841 Million
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 06, 2024	SELL	$73.27 - $83.09 $4,396 - $4,985	-60 Reduced 1.55%	3,800 $307,000
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $15,202 - $17,340	-200 Reduced 4.93%	3,860 $297,000
Q4 2022 Feb 13, 2023	SELL	$62.32 - $89.47 $99,712 - $143,152	-1,600 Reduced 28.27%	4,060 $348,000
Q3 2022 Oct 21, 2022	SELL	$59.54 - $68.01 $83,356 - $95,214	-1,400 Reduced 19.83%	5,660 $349,000
Q2 2022 Aug 09, 2022	SELL	$57.72 - $65.01 $287,676 - $324,009	-4,984 Reduced 41.38%	7,060 $436,000
Q4 2021 Jan 20, 2022	SELL	$64.88 - $73.64 $47,038 - $53,389	-725 Reduced 5.68%	12,044 $875,000
Q1 2021 Apr 22, 2021	SELL	$60.0 - $68.46 $225,960 - $257,820	-3,766 Reduced 22.78%	12,769 $825,000
Q4 2020 Jan 19, 2021	SELL	$56.65 - $64.55 $70,982 - $80,881	-1,253 Reduced 7.04%	16,535 $963,000
Q3 2020 Nov 03, 2020	SELL	$62.1 - $78.08 $779,044 - $979,513	-12,545 Reduced 41.36%	17,788 $1.12 Million
Q2 2020 Jul 09, 2020	SELL	$72.34 - $84.0 $130,139 - $151,116	-1,799 Reduced 5.6%	30,333 $2.33 Million
Q1 2020 Apr 08, 2020	BUY	$62.63 - $80.22 $39,018 - $49,977	623 Added 1.98%	32,132 $2.4 Million
Q4 2019 Jan 10, 2020	SELL	$61.62 - $67.78 $18,486 - $20,334	-300 Reduced 0.94%	31,509 $2.05 Million
Q3 2019 Oct 09, 2019	BUY	$62.51 - $69.0 $34,380 - $37,950	550 Added 1.76%	31,809 $2.02 Million
Q2 2019 Jul 16, 2019	BUY	$61.87 - $69.38 $7,238 - $8,117	117 Added 0.38%	31,259 $2.11 Million
Q1 2019 Apr 08, 2019	SELL	$62.53 - $70.05 $36,454 - $40,839	-583 Reduced 1.84%	31,142 $2.03 Million
Q4 2018 Jan 24, 2019	SELL	$60.54 - $79.0 $75,675 - $98,750	-1,250 Reduced 3.79%	31,725 $1.98 Million
Q2 2018 Jul 13, 2018	SELL	$64.88 - $75.68 $11,678 - $13,622	-180 Reduced 0.54%	32,975 $2.34 Million
Q1 2018 Apr 17, 2018	SELL	$72.84 - $88.8 $18,210 - $22,200	-250 Reduced 0.75%	33,155 $2.5 Million
Q4 2017 Jan 22, 2018	BUY	$71.15 - $83.52 $10,672 - $12,528	150 Added 0.45%	33,405 $2.39 Million
Q3 2017 Oct 11, 2017	BUY	$72.11 - $85.47 $2.4 Million - $2.84 Million	33,255	33,255 $2.69 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Forte Capital LLC , based on Form 13F filings with the SEC.

News

Stay updated on Forte Capital LLC with notifications on news.

Account